Evidence map›Paper›PMID 35428698›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2022

KL1 Domain of Longevity Factor Klotho Mimics the Metabolome of Cognitive Stimulation and Enhances Cognition in Young and Aging Mice.

Shweta Gupta, Arturo J Moreno, Dan Wang, Julio Leon, Chen Chen, Oliver Hahn, Yan Poon, Kenneth Greenberg, Nathaniel David, Tony Wyss-Coray and 3 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07216781 (Evaluating the Safety and Efficacy of Injectable Klotho Plasmid Gene Therapy in Humans), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07216781 phase1active not recruitingnot on this mapstarted 2025, after this paper: background citation

Evaluating the Safety and Efficacy of Injectable Klotho Plasmid Gene Therapy in Humans: An Interventional, Non-Placebo-Controlled Pilot Phase Study

TypeinterventionalSponsorMinicircleRan2025 to 2026Enrolled14ConditionsHealthy AdultsArmsInjectable Plasmid Klotho Gene Therapy
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Frontiers in aging neuroscience · 2025
    Article
  9. Amyloid-β positivity is less prevalent in cognitively unimpairedJournal of Alzheimer's disease : JAD · 2024
    Article
  10. Review
  11. A second X chromosome improves cognition in aging male and female mice.bioRxiv : the preprint server for biology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. X Chromosome Factor Kdm6a Enhances Cognition Independent of Its Demethylase Function in the Aging XY Male Brain.The journals of gerontology. Series A, Biological sciences and medical sciences · 2023
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Shweta GuptaDepartment of Neurology and Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94143-1207.
Arturo J MorenoDepartment of Neurology and Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94143-1207.
Dan WangDepartment of Neurology and Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94143-1207.
Julio LeonDepartment of Neurology and Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94143-1207.
Chen ChenDepartment of Neurology and Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94143-1207.
Oliver HahnDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305-5101.
Yan PoonUnity Biotechnology, Inc, South San Francisco 94080.
Kenneth GreenbergUnity Biotechnology, Inc, South San Francisco 94080.
Nathaniel DavidUnity Biotechnology, Inc, South San Francisco 94080.
Tony Wyss-CorayDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305-5101.
Daniel RafteryDepartment of Anesthesiology and Pain Medicine, Mitochondria and Metabolism Center, University of Washington, Seattle, Washington 98109-4714.ORCID https://orcid.org/0000-0003-2467-8118
Daniel E L PromislowDepartment of Lab Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington 98195-7470.
Dena B DubalDepartment of Neurology and Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94143-1207 Dena.Dubal@ucsf.edu.ORCID https://orcid.org/0000-0001-7504-4372
University of California, San Francisco · USUnity Biotechnology (United States) · USUniversity of Washington · USNeurosciences Institute · USStanford University · US

Funding

University of Washington Nathan Shock Center of Excellence in the Basic Biology of AgingP30AG013280 · NIA · UNIVERSITY OF WASHINGTON · PI Michael MacCoss · 1995 to 2026
$27.1M
Collagen VI: Novel Mechanisms and Functions in Alzheimer's DiseaseK08AG034531 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DUBAL, DENA BOU · 2009 to 2013
$540k
NIA NIH HHS K08 AG034531NIA NIH HHS P30 AG013280
6 · The paper itself

Abstract

Cognitive deficits are a major biomedical challenge-and engagement of the brain in stimulating tasks improves cognition in aged individuals (Wilson et al., 2002; Gates et al., 2011) and rodents (Aidil-Carvalho et al., 2017), through unknown mechanisms. Whether cognitive stimulation alters specific metabolic pathways in the brain is unknown. Understanding which metabolic processes are involved in cognitive stimulation is important because it could lead to pharmacologic intervention that promotes biological effects of a beneficial behavior, toward the goal of effective medical treatments for cognitive deficits. Here we show using male mice that cognitive stimulation induced metabolic remodeling of the mouse hippocampus, and that pharmacologic treatment with the longevity hormone α-klotho (KL), mediated by its KL1 domain, partially mimicked this alteration. The shared, metabolic signature shared between cognitive stimulation and treatment with KL or KL1 closely correlated with individual mouse cognitive performance, indicating a link between metabolite levels and learning and memory. Importantly, the treatment of mice with KL1, an endogenous circulating factor that more closely mimicked cognitive stimulation than KL, acutely increased synaptic plasticity, a substrate of cognition. KL1 also improved cognition, itself, in young mice and countered deficits in old mice. Our data show that treatments or interventions mimicking the hippocampal metabolome of cognitive stimulation can enhance brain functions. Further, we identify the specific domain by which klotho promotes brain functions, through KL1, a metabolic mimic of cognitive stimulation.

Indexed as

GlucuronidaseLongevityAgingAnimalsCognitionHydrolasesKlotho ProteinsMaleMetabolomeMiceGlucuronidaseHydrolasesKlotho Proteinsagingbioinformaticscognitionklothometabolismsynaptic plasticity

Identifiers

PMID35428698
PMCPMC9097772
OpenAlexW4223904987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.